Skip to main content
. 2013 Dec 5;4:162. doi: 10.3389/fpsyt.2013.00162

Table 1.

Demographic and clinical characteristics of the participants.

Characteristic HC (n = 49)
SCZ (n = 72)
BD (n = 42)
Statistical analysis
SCZ vs. BD
All three groups
Mean SD Mean SD Mean SD t-test p F-test p
Age 31.9 10.4 31.47 8.29 32.57 9.673 −0.642 0.522 0.191 0.827
Subject’s years of education 13.59 1.62 12.31 2.039 12.15 2.291 0.364 0.717 7.849 0.001*
Father’s years of education 8.53 4.22 7.62 3.697 7.31 3.317 0.447 0.655 1.454 0.237
Mother’s years of education 7.88 4.29 6.93 3.815 4.98 4.129 2.551 0.012* 6.228 0.002*
WRAT scores 49.78 4.25 49.75 5.301 49.88 4.994 −0.13 0.897 0.75 0.474
Duration of illness 4.77 5.317 3.32 56.39 1.394 0.166
Age of onset 26.69 8.073 28.24 9.294 −0.931 0.354
Duration of untreated psychosis 1.715 2.206 0.296 0.528 4.094 <0.001*
Mean daily CPZ mg equivalents 185.76 197.47 157.38 174.89 0.771 0.442
GAF scores
 Total 50.18 18.821 64.9 21.101 −3.852 <0.001*
 Symptoms 54.36 20.292 64.98 21.39 −2.641 0.009*
 Disability 51.46 19.092 65.69 19.749 −3.791 <0.001*
PANSS
 Positive symptoms 10.79 3.715 8.55 2.839 3.379 0.001*
 Negative symptoms 8.33 2.116 7.05 0.309 3.906 <0.001*
 General psychopathology 20.89 3.71 17.79 1.828 5.067 <0.001*
 Total score 40.01 7.135 33.38 4.120 5.506 <0.001*
YMRS 1.56 2.469 3.4 4.607 2.485 0.015*

N % N % N % χ2 p χ2 p

Male 28 57.1 38 52.8 17 40.5 1.608 0.205 2.442 0.295
Right-handed 46 93.9 70 97.2 40 97.6 1.148 0.284 1.102 0.576

BD, bipolar disorder; CPZ, chlorpromazine; GAF, global assessment of functioning; HC, healthy controls; PANSS, positive and negative syndrome scale; SCZ, schizophrenia; WRAT, wide range achievement test; YMRS, young mania rating scale. *p < 0.05.